Coming Soon

Season 1: Network Effects
Unlock exponential growth
Master the 16 network effects
20 years of insights in one class
Investor List:

Top Pharmaceuticals Series A Investors in New York City (29)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of David Bonita, General Partner at OrbiMed
David Bonita
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Jared Newman, Investor at Canaan Partners
Jared Newman
Canaan Partners·Investor
Sweet spot: $10.0M
Range: $250K - $20.0M
Investors in New York City
Investors in BioTech, Investors in BioTech, Investors in Cloud Infrastructure, Investors in Cloud Infrastructure, Investors in Consumer Health, Investors in Consumer Health, Investors in Consumer Internet, Investors in Consumer Internet, Investors in FinTech, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of W. Carter Neild, Managing Partner at OrbiMed
W. Carter Neild
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Carl  Gordon, Managing Partner at OrbiMed
Carl Gordon
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Medical Devices, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Tim Shannon, General Partner at Canaan Partners
Tim Shannon
Canaan Partners·General Partner
Sweet spot: $10.0M
Range: $250K - $20.0M
Investors in Westport (CT), Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Sven Borho, Managing Partner at OrbiMed
Sven Borho
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Trevor Polischuk, Partner at OrbiMed
Trevor Polischuk
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of William Sawyer, Partner at OrbiMed
William Sawyer
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Get new data & insights delivered to your inbox